Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Colistin Induced Assortment of Antimicrobial Resistance in a Clinical Isolate of Acinetobacter baumannii SD01

Author(s): Debarati Paul*, Swarupa Mallick, Swati Das, Suman Saha, Ananta K. Ghosh and Santi M. Mandal*

Volume 20, Issue 4, 2020

Page: [501 - 505] Pages: 5

DOI: 10.2174/1871526519666190426153258

Price: $65

Abstract

Background: Colistin was considered as the most effective antibiotic against Acinetobacter baumannii, a widely-known opportunistic pathogen. In recent years, a number of colistin resistant strains have also been reported.

Objective: This work is commenced to investigate the contribution of efflux pumps toward resistance to colistin-like cyclic polypeptide antibiotics, since the efflux pumps serve as the escape routes leading to drug-resistance.

Methods: RNA was extracted from A. baumannii isolates cultured from samples procured by tracheal aspiration of infected patients. The expressions of gene(s) that played major roles in the regulation of efflux pump families and involvement of integron systems were studied using real time PCR. Antimicrobial susceptibility tests were conducted to investigate antibiotic resistance of the isolates.

Results: It was observed that genes coding for sugE, ydhE, ydgE, mdfA, ynfA and tolC significantly contributed to resistance against colistin antibiotics, however, no significant transcriptional change was observed in the efflux pump, MexAB-OprM. Results suggest that A. baumanii readily pumps out colistin via efflux pumps belonging to MATE and SMR family.

Conclusion: Integral role of efflux pumps and integron 1 genetic system was elucidated towards evolution of multi-drug resistant strain(s). Therefore, for accurate therapeutics, an early detection of efflux genes is crucial before prescribing against colistin resistant A. baumanii.

Keywords: Acinetobacter baumannii, antibiotics; colistin, efflux pumps, integron, multi-antibiotic.

[1]
Nield, B.S.; Holmes, A.J.; Gillings, M.R.; Recchia, G.D.; Mabbutt, B.C.; Nevalainen, K.M.; Stokes, H.W. Recovery of new integron classes from environmental DNA. FEMS Microbiol. Lett., 2001, 195(1), 59-65.
[http://dx.doi.org/10.1111/j.1574-6968.2001.tb10498.x] [PMID: 11166996]
[2]
Gillings, M.R. Integrons: past, present, and future. Microbiol. Mol. Biol. Rev., 2014, 78(2), 257-277.
[http://dx.doi.org/10.1128/MMBR.00056-13] [PMID: 24847022]
[3]
Martins, N.; Picão, R.C.; Adams-Sapper, S.; Riley, L.W.; Moreira, B.M. Association of class 1 and 2 integrons with multidrug resistant Acinetobacter baumannii international clones and Acinetobacter nosocomialis isolates. Antimicrob. Agents Chemother., 2015, 59(1), 698-701.
[http://dx.doi.org/10.1128/AAC.02415-14] [PMID: 25348522]
[4]
Lomovskaya, O.; Warren, M.S.; Lee, A.; Galazzo, J.; Fronko, R.; Lee, M.; Blais, J.; Cho, D.; Chamberland, S.; Renau, T.; Leger, R.; Hecker, S.; Watkins, W.; Hoshino, K.; Ishida, H.; Lee, V.J. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother., 2001, 45(1), 105-116.
[http://dx.doi.org/10.1128/AAC.45.1.105-116.2001] [PMID: 11120952]
[5]
Paulsen, I.T.; Brown, M.H.; Skurray, R.A. Proton-dependent multidrug efflux systems. Microbiol. Rev., 1996, 60(4), 575-608.
[http://dx.doi.org/10.1128/MMBR.60.4.575-608.1996] [PMID: 8987357]
[6]
Saier, M.H., Jr; Paulsen, I.T. Phylogeny of multidrug transporters. Semin. Cell Dev. Biol., 2001, 12(3), 205-213.
[http://dx.doi.org/10.1006/scdb.2000.0246] [PMID: 11428913]
[7]
Piddock, L.J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev., 2006, 19(2), 382-402.
[http://dx.doi.org/10.1128/CMR.19.2.382-402.2006] [PMID: 16614254]
[8]
Webber, M.A.; Piddock, L.J.V. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother., 2003, 51(1), 9-11.
[http://dx.doi.org/10.1093/jac/dkg050] [PMID: 12493781]
[9]
Llanes, C.; Hocquet, D.; Vogne, C.; Benali-Baitich, D.; Neu-wirth, C.; Plésiat, P. Clinical strains of overproducing of ef-flux pumps simultaneously. Antimicrob. Agents Chemother., 2004, 48, 1797-1802.
[http://dx.doi.org/10.1128/AAC.48.5.1797-1802.2004] [PMID: 15105137]
[10]
Gould, V.C.; Okazaki, A.; Avison, M.B. Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends drug resistance in Stenotrophomonas maltophilia. Antimicrob. Agents Chemother., 2013, 57(1), 655-657.
[http://dx.doi.org/10.1128/AAC.01020-12] [PMID: 23147729]
[11]
Poole, K. Efflux pumps as antimicrobial resistance mechanisms. Ann. Med., 2007, 39(3), 162-176.
[http://dx.doi.org/10.1080/07853890701195262] [PMID: 17457715]
[12]
Van Bambeke, F.; Balzi, E.; Tulkens, P.M. Antibiotic efflux pumps. Biochem. Pharmacol., 2000, 60(4), 457-470.
[http://dx.doi.org/10.1016/S0006-2952(00)00291-4] [PMID: 10874120]
[13]
Mandal, S.M.; Hegde, M.L.; Chatterjee, A.; Hegde, P.M.; Szczesny, B.; Banerjee, D.; Boldogh, I.; Gao, R.; Falkenberg, M.; Gustafsson, C.M.; Sarkar, P.S.; Hazra, T.K. Role of human DNA glycosylase Nei-like 2 (NEIL2) and single strand break repair protein polynucleotide kinase 3′-phosphatase in maintenance of mitochondrial genome. J. Biol. Chem., 2012, 287(4), 2819-2829.
[http://dx.doi.org/10.1074/jbc.M111.272179] [PMID: 22130663]
[14]
Lin, M.F.; Chang, K.C.; Yang, C.Y.; Yang, C.M.; Xiao, C.C.; Kuo, H.Y.; Liou, M.L. Role of integrons in antimicrobial susceptibility patterns of Acinetobacter baumannii. Jpn. J. Infect. Dis., 2010, 63(6), 440-443.
[PMID: 21099097]
[15]
Shiba, T.; Ishiguro, K.; Takemoto, N.; Koibuchi, H.; Sugimoto, K. Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene. J. Bacteriol., 1995, 177(20), 5872-5877.
[http://dx.doi.org/10.1128/JB.177.20.5872-5877.1995] [PMID: 7592337]
[16]
Liu, C.C.; Tang, C.Y.; Chang, K.C.; Kuo, H.Y.; Liou, M.L. A comparative study of class 1 integrons in Acinetobacter baumannii. Gene, 2014, 544(1), 75-82.
[http://dx.doi.org/10.1016/j.gene.2014.04.047] [PMID: 24768721]
[17]
Koczura, R.; Przyszlakowska, B.; Mokracka, J.; Kaznowski, A. Class 1 integrons and antibiotic resistance of clinical Acinetobacter calcoaceticus-baumannii complex in Poznań, Poland. Curr. Microbiol., 2014, 69(3), 258-262.
[http://dx.doi.org/10.1007/s00284-014-0581-0] [PMID: 24740302]
[18]
Sarkar, S.K.; Bhattacharyya, A.; Mandal, S.M. YnfA, a SMR family efflux pump is abundant in Escherichia coli isolates from urinary infection. Indian J. Med. Microbiol., 2015, 33(1), 139-142.
[http://dx.doi.org/10.4103/0255-0857.148415] [PMID: 25560019]
[19]
Yoon, E.J.; Courvalin, P.; Grillot-Courvalin, C. RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations. Antimicrob. Agents Chemother., 2013, 57(7), 2989-2995.
[http://dx.doi.org/10.1128/AAC.02556-12] [PMID: 23587960]
[20]
Srinivasan, V.B.; Rajamohan, G.; Gebreyes, W.A. Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii. Antimicrob. Agents Chemother., 2009, 53(12), 5312-5316.
[http://dx.doi.org/10.1128/AAC.00748-09] [PMID: 19770280]
[21]
Lin, M.F.; Lin, Y.Y.; Lan, C.Y. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J. Microbiol., 2017, 55(2), 130-136.
[http://dx.doi.org/10.1007/s12275-017-6408-5] [PMID: 28120193]
[22]
Poole, K.; Tetro, K.; Zhao, Q.; Neshat, S.; Heinrichs, D.E.; Bianco, N. Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob. Agents Chemother., 1996, 40(9), 2021-2028.
[http://dx.doi.org/10.1128/AAC.40.9.2021] [PMID: 8878574]
[23]
Lobedanz, S.; Bokma, E.; Symmons, M.F.; Koronakis, E.; Hughes, C.; Koronakis, V. The assembly of bacterial drug ef-flux pumps. Proc. Natl. Acad. Sci. USA, 2007, 104, 4612-4617.
[http://dx.doi.org/10.1073/pnas.0610160104] [PMID: 17360572]
[24]
Edgar, R.; Bibi, E. MdfA, an Escherichia coli multidrug resistance protein with an extraordinarily broad spectrum of drug recognition. J. Bacteriol., 1997, 179(7), 2274-2280.
[http://dx.doi.org/10.1128/JB.179.7.2274-2280.1997] [PMID: 9079913]
[25]
Livermore, D.M.; Hill, R.L.; Thomson, H.; Charlett, A.; Turton, J.F.; Pike, R.; Patel, B.C.; Manuel, R.; Gillespie, S.; Balakrishnan, I.; Barrett, S.P.; Cumberland, N.; Twagira, M. C-MRAB Study Group. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London. Int. J. Antimicrob. Agents, 2010, 35(1), 19-24.
[http://dx.doi.org/10.1016/j.ijantimicag.2009.09.014] [PMID: 19910162]

Rights & Permissions Print Cite
Article Metrics
8
© 2024 Bentham Science Publishers | Privacy Policy